2.Chinese expert consensus on multidisciplinary treatment of bone metastasis from colorectal cancer (2020 version).
Chinese Journal of Oncology 2020;42(6):433-437
With the extension of survival period and the improvement of imaging technology, the incidence of bone metastasis from colorectal cancer gradually increases. Therefore, the early diagnosis and treatment of bone metastasis should not be neglected while the primary lesion was controlled.Currently, the available evidence for bone metastasis from colorectal cancer is very limited. In this article, the Chinese Society of Colorectal Cancer organized multi-disciplinary experts to integrate the relevant studies worldwide and combine with clinical practice, focused on the issues and controversies about clinical characteristics, diagnosis and treatment, and follow-up of bone metastatic patients with colorectal cancer.After discussion and voting, Chinese expert consensus on multidisciplinary treatment of bone metastasis from colorectal cancer (2020 version) was formed. This consensus could provide clinicians with more detailed multidisciplinary treatment strategies for bone metastasis from colorectal cancer.
Asian Continental Ancestry Group
;
Bone Neoplasms
;
pathology
;
secondary
;
therapy
;
China
;
Colonic Neoplasms
;
diagnosis
;
therapy
;
Colorectal Neoplasms
;
diagnosis
;
therapy
;
Consensus
;
Humans
;
Interdisciplinary Communication
;
Patient Care Team
;
Practice Guidelines as Topic
;
Treatment Outcome
3.Chinese Medical Association guidelines for clinical diagnosis and treatment of lung cancer (2019 edition).
Chinese Journal of Oncology 2020;42(4):257-287
The formulation of the guidelines for the clinical diagnosis and treatment of lung cancer in line with China's national conditions and multiple discipline cooperation plays an important role in standardizing prevention measures and improving the diagnosis and treatment of lung cancer in China. In order to further improve the diagnosis and treatment of lung cancer in China, improve the outcomes of patients, and provide professional evidence-based medicine advice to clinicians at all levels, the Chinese Medical Association organized specialists in departments of pulmonary medicine, oncology medicine, thoracic surgery, radiotherapy, radiology and pathology throughout the country to perform the work. The recent advances in pathology, genetic testing, immuno-molecule testing, and therapeutic approaches were integrated and the guideline was formulated in combination with international guidelines and China's national conditions. The guideline aims to provide evidence-based, guidance for clinicians at all levels. The guideline covers the screening, diagnosis, pathology, treatment and follow-up of lung cancer.
Asian Continental Ancestry Group
;
China
;
Humans
;
Lung Neoplasms
;
diagnosis
;
therapy
;
Practice Guidelines as Topic
5.Key Points of the 2019 Japanese Society of Hypertension Guidelines for the Management of Hypertension
Korean Circulation Journal 2019;49(12):1123-1135
The new 2019 Japanese Society of Hypertension (JSH) guidelines for the management of hypertension are now available; these update the previous guidelines published in 2014. The primary objective of the guideline is to provide all healthcare professionals with a standard management strategy and appropriate antihypertensive treatments to prevent hypertension-related target organ damage and cardiovascular events. The major changes in the new guideline relate to the definition of normal blood pressure (BP) and target BP. The terms ‘normal BP’ and ‘high normal BP’ used in the JSH 2014 guidelines are replaced with terms ‘high normal BP’ and ‘elevated BP,’ respectively. There was no change to the office BP diagnostic threshold for hypertension (140/90 mmHg). Recommended target office and home BP values for patients with hypertension aged <75 years and/or high-risk patients are <130/80 mmHg and <125/75 mmHg, respectively. Corresponding targets for elderly patients with hypertension (age≥75 years) are 140/90 and 135/85 mmHg, respectively. The goal is that these changes will contribute to reducing cardiovascular events, especially stroke and heart failure, in Japan. The dissemination of the JSH 2019 guidelines and implementation of a home BP-based approach by all general practitioners in Japan might be facilitated by digital hypertension management using health information technology.
Aged
;
Antihypertensive Agents
;
Asian Continental Ancestry Group
;
Blood Pressure
;
Delivery of Health Care
;
Evidence-Based Practice
;
General Practitioners
;
Heart Failure
;
Humans
;
Hypertension
;
Japan
;
Medical Informatics
;
Stroke
6.The Role of Two Human Milk Oligosaccharides, 2′-Fucosyllactose and Lacto-N-Neotetraose, in Infant Nutrition
Badriul HEGAR ; Yulianti WIBOWO ; Ray Wagiu BASROWI ; Reza Gunadi RANUH ; Subianto Marto SUDARMO ; Zakiudin MUNASIR ; Alpha Fardah ATTHIYAH ; Ariani Dewi WIDODO ; SUPRIATMO ; Muzal KADIM ; Ahmad SURYAWAN ; Ninung Rose DIANA ; Christy MANOPPO ; Yvan VANDENPLAS
Pediatric Gastroenterology, Hepatology & Nutrition 2019;22(4):330-340
Human breast milk contains numerous biomolecules. Human milk oligosaccharides (HMOs) are the third most abundant component of breast milk, after lactose and lipids. Amongst the synthetized HMOs, 2′-fucosyllactose (2′-FL) and lacto-N-neotetraose (LNnT) are widely studied and are considered safe for infant nutrition. Several studies have reported the health benefits of HMOs, which include modulation of the intestinal microbiota, anti-adhesive effect against pathogens, modulation of the intestinal epithelial cell response, and development of the immune system. The amount and diversity of HMOs are determined by the genetic background of the mothers (HMO secretors or non-secretors). The non-secretor mothers secrete lower HMOs than secretor mothers. The breastfed infants of secretor mothers gain more health benefit than those of non-secretor mothers. In conclusion, supplementation of infant formula with 2′-FL and LNnT is a promising innovation for infant nutrition.
Breast Feeding
;
Epithelial Cells
;
Gastrointestinal Microbiome
;
Genetic Background
;
Health Maintenance Organizations
;
Humans
;
Immune System
;
Infant Formula
;
Infant
;
Insurance Benefits
;
Lactose
;
Milk, Human
;
Mothers
;
Oligosaccharides
7.Best practices on immunomodulators and biologic agents for ulcerative colitis and Crohn's disease in Asia
Choon Jin OOI ; Ida HILMI ; Rupa BANERJEE ; Sai Wei CHUAH ; Siew Chien NG ; Shu Chen WEI ; Govind K MAKHARIA ; Pises PISESPONGSA ; Min Hu CHEN ; Zhi Hua RAN ; Byong Duk YE ; Dong Il PARK ; Khoon Lin LING ; David ONG ; Vineet AHUJA ; Khean Lee GOH ; Jose SOLLANO ; Wee Chian LIM ; Wai Keung LEUNG ; Raja Affendi Raja ALI ; Deng Chyang WU ; Evan ONG ; Nazri MUSTAFFA ; Julajak LIMSRIVILAI ; Tadakazu HISAMATSU ; Suk Kyun YANG ; Qin OUYANG ; Richard GEARY ; Janaka H DE SILVA ; Rungsun RERKNIMITR ; Marcellus SIMADIBRATA ; Murdani ABDULLAH ; Rupert WL LEONG ;
Intestinal Research 2019;17(3):285-310
The Asia-Pacific Working Group on inflammatory bowel disease (IBD) was established in Cebu, Philippines, under the auspices of the Asian Pacific Association of Gastroenterology with the goal of improving IBD care in Asia. This consensus is carried out in collaboration with Asian Organization for Crohn's and Colitis. With biologic agents and biosimilars becoming more established, it is necessary to conduct a review on existing literature and establish a consensus on when and how to introduce biologic agents and biosimilars in the conjunction with conventional treatments for ulcerative colitis (UC) and Crohn's disease (CD) in Asia. These statements also address how pharmacogenetics influence the treatments of UC and CD and provide guidance on response monitoring and strategies to restore loss of response. Finally, the review includes statements on how to manage treatment alongside possible hepatitis B and tuberculosis infections, both common in Asia. These statements have been prepared and voted upon by members of IBD workgroup employing the modified Delphi process. These statements do not intend to be all-encompassing and future revisions are likely as new data continue to emerge.
Adalimumab
;
Asia
;
Asian Continental Ancestry Group
;
Biological Factors
;
Biosimilar Pharmaceuticals
;
Colitis
;
Colitis, Ulcerative
;
Consensus
;
Cooperative Behavior
;
Crohn Disease
;
Gastroenterology
;
Hepatitis B
;
Humans
;
Immunologic Factors
;
Inflammatory Bowel Diseases
;
Infliximab
;
Pharmacogenetics
;
Philippines
;
Practice Guidelines as Topic
;
Tuberculosis
;
Ulcer
8.Practical Examples of the Comprehensive Strategy of Japanese Dementia Policy: Kumamoto Model by Kumamoto Province
Health Policy and Management 2019;29(1):11-18
The purpose of this research is to introduce the best practice of the Japanese national dementia strategy and explore implications to the Korean national dementia strategy. Interview was conducted among professions those who is in charge of Kumamoto dementia care practice in Kumamoto province, upon review of related literature and public documents. The Kumamoto model is implemented by the department of neuropsychiatry in public university hospitals, which can offer dementia-specialized medical services. Medical centers for dementia in public university hospitals play a leading role for managing practice and training local dementia centers specialist, coordinating medical services among medical institutions and community welfare facilities. In reference to the Kumamoto model, the Korean national dementia strategy can find implications in the direction of current system, specifically its approaches toward policy governance.
Asian Continental Ancestry Group
;
Dementia
;
Hospitals, University
;
Humans
;
Japan
;
Neuropsychiatry
;
Practice Guidelines as Topic
;
Specialization
9.A coordination project for improvement of osteoporosis medication use among patients who sustained an osteoporotic fracture: The Israeli experience
Noemi HEYMAN ; Isaac ETZION ; Merav BEN NATAN
Osteoporosis and Sarcopenia 2018;4(4):134-139
OBJECTIVES: The aim of this study was to examine whether coordination between healthcare providers at an inpatient rehabilitation facility and healthcare providers in a community setting improves osteoporosis medication use in the community. METHODS: In 2012, a coordination project between an inpatient geriatric rehabilitation facility located in north-central Israel and general practitioners in the community setting was initiated. In this retrospective pseudo-experimental study, we compared osteoporosis medication use among patients who were hospitalized at the facility following an osteoporotic fracture during 2011–2012, and who constituted the control group (n=20), and patients who were hospitalized at the facility during 2013–2015, and who constituted the trial group (n=129). Data were collected from the patients' records and from records of the health maintenance organization concerning medications issued to the patients by pharmacies. RESULTS: Differences were observed between the trial and the control group in osteoporosis medication management by healthcare providers, both at the inpatient rehabilitation facility and in the community, suggesting favorable trends. However, osteoporosis medication use in the community was slightly lower in the trial group, then in the control group (32.8% vs. 34.2%, respectively). A regression analysis indicated that the only variable predicting use of osteoporosis medications in the community was a previous diagnosis of osteoporosis in the community. CONCLUSIONS: The study results indicate that mere coordination between the healthcare settings is insufficient in order to ensure continued care in the community, emphasizing the need for an osteoporosis coordinator.
Delivery of Health Care
;
Diagnosis
;
General Practitioners
;
Health Maintenance Organizations
;
Health Personnel
;
Humans
;
Inpatients
;
Israel
;
Osteoporosis
;
Osteoporotic Fractures
;
Pharmacies
;
Rehabilitation
;
Retrospective Studies
10.Survey on the undergraduate curriculum in clinical pharmacology and interns' prescribing ability in South Korea
Namyi GU ; Kyong Jee KIM ; Chi Yeon LIM ; Jun Kyu LEE ; Moo Yong RHEE ; Kwang Hee SHIN ; Seung Hwan LEE ; Sangzin AHN
Translational and Clinical Pharmacology 2018;26(3):128-133
Appropriate prescription writing is one of the critical medical processes affecting the quality of public health care. However, this is a complex task for newly qualified intern doctors because of its complex characteristics requiring sufficient knowledge of medications and principles of clinical pharmacology, skills of diagnosis and communication, and critical judgment. This study aims to gather data on the current status of undergraduate prescribing education in South Korea. Two surveys were administered in this study: survey A to 26 medical schools in South Korea to gather information on the status of undergraduate education in clinical pharmacology; and survey B to 244 intern doctors in large hospitals to gather their opinions regarding prescribing education and ability. In survey A, half of the responding institutions provided prescribing education via various formats of classes over two curriculums including lecture, applied practice, group discussions, computer-utilized training, and workshops. In survey B, we found that intern doctors have the least confidence when prescribing drugs for special patient populations, especially pregnant women. These intern doctors believed that a case-based practical training or group discussion class would be an effective approach to supplement their prescribing education concurrently or after the clerkship in medical schools or right before starting intern training with a core drug list. The results of the present study may help instructors in charge of prescribing education when communicating and cooperating with each other to improve undergraduate prescribing education and the quality of national medical care.
Curriculum
;
Diagnosis
;
Education
;
Education, Medical
;
Female
;
Group Practice
;
Humans
;
Judgment
;
Korea
;
Pharmacology, Clinical
;
Pregnant Women
;
Prescriptions
;
Public Health
;
Schools, Medical
;
Writing

Result Analysis
Print
Save
E-mail